ISCT 2023: MSCs & MSC-EVs Maturing Into a Mainstream Cell Therapy Topic

By Stephen Lenzini

Many diverse company booths were represented at the 2023 annual meeting of the International Society of Cell and Gene Therapy (ISCT), and due to the broader interest in the cell therapy field, the primary focus was upstream methods for cellular therapies. The exhibit hall was packed with >150 company exhibits, including a vibrant exhibit space provided by RoosterBio.

RoosterBio contributed 3 scientific posters and in one roundtable session and additionally, an oral presentation in the EV/Exosome session titled “Successful Development of a Scalable & Robust Process for MSC-EV Production” was presented to showcase the large-scale capability of MSC-EV production at RoosterBio.